δείτε την πρωτότυπη σελίδα τεκμηρίου στον ιστότοπο του αποθετηρίου του φορέα για περισσότερες πληροφορίες και για να δείτε όλα τα ψηφιακά αρχεία του τεκμηρίου*
The greek pharmaceutical industry: problems and future prospects.
Giannaki, Anastasia
Γιαννάκη, Αναστασία
Δεληπάλλα, Σοφία
Πρόγραμμα Μεταπτυχιακών Σπουδών στις Πολιτικές και Οικονομικές Σπουδές Σύγχρονης Ανατολικής και Νοτιοανατολικής Ευρώπης
Delipalla, Sofia
The theme of the specific thesis analyses the social, constitutional and
regulatory characteristics of the pharmaceutical market in Greece which is regulated
extensively by the state though periodic public-controlling measures affecting both
the demand and supply side for pharmaceuticals in order to restrict pharmaceutical
expenditure. Pharmaceutical expenditure’s steady increase, however, coupled with a
period of deep recession and consequently a program of fiscal stabilization reforms
which Greece is facing nowadays, are threatening the constitutional and financial
viability of the pharmaceutical industry making it now more imperative than ever for
a comprehensive pharmaceutical policy to be formulated and implemented which
would stabilize the structure of the pharmaceutical system.
In the first part the factors which affect domestic demand together with the
epidemiological and demographic factors which contributed to the health status of the
Greek state will be extensively described. Moreover, the expenditure patterns of the
pharmaceutical industry and its fluctuations in Greece during the last decade will be
analyzed. The main features of Greece’s pharmaceutical industry which are its supply
structures and the existing regulatory and institutional framework will also be referred
to with elaborate detail below. Furthermore, public policy's role and the measures
which focus on the restructuring of the pharmaceutical market and the decrease of its
expenditure will likewise be referenced to, while a brief analysis of government
measures which have been adapted as part of the fiscal stabilization program in
Greece will also be touched upon. Last but not least, the thesis ends with an extensive
reference to the problems pharmaceutical companies face resulting from the Greek
government’s interventions and on a proposal for an alternative regulatory solution
that would constitute an efficient and stable pharmaceutical environment for the
Greek pharmaceutical industry and ensure the sustainability of future prospects.
Πανεπιστήμιο Μακεδονίας Οικονομικών και Κοινωνικών Επιστημών
*Η εύρυθμη και αδιάλειπτη λειτουργία των διαδικτυακών διευθύνσεων των συλλογών (ψηφιακό αρχείο, καρτέλα τεκμηρίου στο αποθετήριο) είναι αποκλειστική ευθύνη των αντίστοιχων Φορέων περιεχομένου.
Βοηθείστε μας να κάνουμε καλύτερο το OpenArchives.gr.
